Galderma to Present New Findings From Innovative Product Portfolio at the 2022 VCS Annual Symposium
Galderma, the leading company solely dedicated to advancing the future of dermatology, announced...
Read MoreSelect Page
Galderma, the leading company solely dedicated to advancing the future of dermatology, announced...
Read MoreGalderma announces that the U.S. Food and Drug Administration (FDA) has...
Read MoreGalderma have unveiled results from an innovative open-label post-marketing study which assessed...
Read MoreGalderma Laboratories, L.P., a global leader focused on medical solutions in skin health, announced that it has received U.S. Food...
Read MoreGalderma, a global leader focused on medical solutions for skin health, announces the publication of results from the Phase 4...
Read MoreNow indicated for Correction of Age Related Volume Loss in the Cheek Area. Galderma, a global healthcare company focused on...
Read MoreGalderma Laboratories, L.P. have announced that the U.S. Food and Drug Administration (FDA) approved antibiotic-free Epiduo® Forte (adapalene and benzoyl...
Read MoreSoolantra® (ivermectin) Cream, 1% found to be well tolerated with powerful results seen as early as two weeks
Read More